Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...
Phase 1b norovirus challenge study is underway at Emory University School of MedicineCDI-988 is the first oral antiviral ...
The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across ...
A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and ...
Chair, President, and CEO Sheila DeWitt, PhD, shares reflections and outlook on 15 Years of Drug Discovery and Four Landmark M&A Transactions BOSTON, March 31, 2026 /PRNewswire/ -- In honor of Women's ...
The Alzheimer's Drug Discovery Foundation (ADDF) today announced the launch of the third phase of its Diagnostics Accelerator (DxA), backed by an additional $50 million in funding, bringing the ...
EXTON, Pa., Jan. 30, 2026 /PRNewswire/ -- Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the expansion of its ...
Drug discovery has long been defined by time, cost, and repeated failure. Medvolt AI is using OpenAI-enabled intelligence to ...
A day after surpassing its own expectations with dazzling Phase III data for its lead pipeline candidate, the oral ulcerative colitis (UC) drug obefazimod, Abivax (Euronext Paris and NASDAQ: ABVX) so ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results